Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0920646 (
renal ischemia
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
There is significant progress in understanding the structure and function of
NLRC5
, a member of the nucleotide oligomerization domain-like receptor family. However, in the context of MHC class I gene expression, the functions of
NLRC5
in innate and adaptive immune responses beyond the regulation of MHC class I genes remain controversial and unresolved. In particular, the role of
NLRC5
in the kidney is unknown.
NLRC5
was significantly upregulated in the kidney from mice with
renal ischemia
/reperfusion injury.
NLRC5
deficient mice significantly ameliorated renal injury as evidenced by decreased serum creatinine levels, improved morphological injuries, and reduced inflammatory responses versus wild type mice. Similar protective effects were also observed in cisplatin-induced acute kidney injury. Mechanistically,
NLRC5
contributed to renal injury by promoting tubular epithelial cell apoptosis and reducing inflammatory responses were, at least in part, associated with the negative regulation of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1). To determine the relative contribution of
NLRC5
expression by parenchymal cells or leukocytes to renal damage during ischemia/reperfusion injury, we generated bone marrow chimeric mice.
NLRC5
deficient mice engrafted with wild type hematopoietic cells had significantly lower serum creatinine and less tubular damage than wild type mice reconstituted with
NLRC5
deficient bone marrow. This suggests that
NLRC5
signaling in renal parenchymal cells plays the dominant role in mediating renal damage. Thus, modulation of the
NLRC5
-mediated pathway may have important therapeutic implications for patients with acute kidney injury.
...
PMID:NLRC5 deficiency protects against acute kidney injury in mice by mediating carcinoembryonic antigen-related cell adhesion molecule 1 signaling. 2990 59